Rennard, S; Bantje, T; Centanni, S et al.
A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comparison.Respir Med. Bd. 102. H. 7. 2008 S. 1033-44
Thomeer, M; Demedts, M; Behr, J et al.
Accuracy of diagnosis of idiopathic pulmonary fibrosisEur Respir J. Bd. 31. H. 3. 2008 S. 585-591
Distler, E; Wolfel, C; Kohler, S et al.
Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.Exp Hematol. Bd. 36. H. 4. 2008 S. 451-63
Heib, V; Becker, M; Taube, C et al.
Advances in the understanding of mast cell function.Br J Haematol. Bd. 142. H. 5. 2008 S. 683-94
Marques, CA; Hahnel, PS; Wolfel, C et al.
An immune escape screen reveals Cdc42 as regulator of cancer susceptibility to lymphocyte-mediated tumor suppression.Blood. Bd. 111. H. 3. 2008 S. 1413-9
Weber, M; Weiher, E; Smeding, RM
Arzt und Trauer.Med Klin (Munich). Bd. 103. H. 7. 2008 S. 532-9
Chapman, CJ; Murray, A; McElveen, JE et al.
Autoantibodies in lung cancer: possibilities for early detection and subsequent cure.Thorax. Bd. 63. H. 3. 2008 S. 228-33
Gonzalez, AV; Ullmann, AJ; Almyroudis, NG et al.
Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: point.J Natl Compr Canc Netw. Bd. 6. H. 2. 2008 S. 175-82
Humbert, M; Andersson, TL; Buhl, R
Budesonide/formoterol for maintenance and reliever therapy in the management of moderate to severe asthma.Allergy. Bd. 63. H. 12. 2008 S. 1567-80
Sahin, U; Koslowski, M; Dhaene, K et al.
Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development.Clin Cancer Res. Bd. 14. H. 23. 2008 S. 7624-34